Literature DB >> 12880639

Ontogenic changes in CD95 expression on human leukocytes: prevalence of T-cells expressing activation markers and identification of CD95-CD45RO+ T-cells in the fetus.

Marcus O Muench1, Eva M Pott Bärtsch, Jeng-Chang Chen, John B Lopoo, Alicia Bárcena.   

Abstract

The ontogeny of the human immune system was studied by analyzing fetal and adult tissues for the presence of various lymphocyte populations and activation/maturation markers. CD95 (fas) was expressed in hematopoietic tissues during the final stages of development of monocytes, granulocytes, NK cells and T cells, but to a much lesser extent on B cells. In the periphery, CD95 expression declined on granulocytes and NK cells. CD95 was expressed at a higher level on CD45RA+ peripheral T-cells in the fetus than in the adult. Contrary to the belief that most fetal T-cells are naïve or resting, a notable number of CD45RO+ T-cells were observed as well as an unique CD95-CD45RO+ population. Activation markers CD25, CD122, CD69 and CD80 were also present on fetal T-cells. These findings indicate that in the initial weeks following thymic maturation, a high frequency of T-cells is activated in the periphery of the fetus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880639     DOI: 10.1016/s0145-305x(03)00081-8

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  3 in total

1.  Cellular therapies supplement: the peritoneum as an ectopic site of hematopoiesis following in utero transplantation.

Authors:  Marcus O Muench; Jeng-Chang Chen; Ashley I Beyer; Marina E Fomin
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

2.  Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans.

Authors:  Jeff E Mold; Shivkumar Venkatasubrahmanyam; Trevor D Burt; Jakob Michaëlsson; Jose M Rivera; Sofiya A Galkina; Kenneth Weinberg; Cheryl A Stoddart; Joseph M McCune
Journal:  Science       Date:  2010-12-17       Impact factor: 47.728

3.  Donor major histocompatibility complex class I expression determines the outcome of prenatal transplantation.

Authors:  Emily T Durkin; Kelly A Jones; Dina Elnaggar; Aimen F Shaaban
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.